Standout Papers

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy 2015 2026 2018 2022 507
  1. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy (2015)
    Jeffrey G. Gross, Adam R. Glassman et al. JAMA

Immediate Impact

74 standout
Sub-graph 1 of 21

Citing Papers

Age-Related Macular Degeneration
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
10 intermediate papers

Works of Brian B. Berger being referenced

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
2020
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
2015 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Brian B. Berger 1132 795 210 212 34 1.4k
Michal Kramer 1260 393 86 180 68 1.5k
Sanford M. Meyers 1021 716 196 234 58 1.4k
P. Andrew Pearson 1179 424 136 110 33 1.5k
Travis A. Meredith 1448 557 276 138 65 1.7k
Perumalsamy Namperumalsamy 966 389 128 251 33 1.3k
Michaella Goldstein 1018 602 78 163 65 1.2k
Friederike Mackensen 1322 266 158 193 64 1.7k
Eric J. Feron 984 664 150 180 23 1.1k
Peter R. Egbert 1036 423 215 83 39 1.5k
Rim Kahloun 773 199 173 123 40 1.0k

All Works

Loading papers...

Rankless by CCL
2026